In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
Nancy Schroeder and her husband Mark
In the Clinic
New Checkpoint Inhibitor Immunotherapy Treatment for Advanced Melanoma Shows Promise

Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This new drug combination also has fewer side effects than other immunotherapy treatments.
Alexandra Joyner, Ming Li, and Kenneth Offit
Three Memorial Sloan Kettering Cancer Center Faculty Members Elected as 2021 AAAS Fellows

Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
Pedram Razavi, Jorge Reis-Filho, and Bob Li
Finding
Many Mutations Detected in Liquid Biopsy Tests Do Not Come from Cancer Cells, an MSK Study Finds

The new findings suggest the need for caution when interpreting the results from these tests.
Pictured: Barbara Raphael & Chioma Enweasor
Learning Curve
Summer Fellowship Gives Medical Students the Tools to Become Physician-Scientists

Our summer fellowship program helps medical students learn to become physician-scientists. Read about one of our trainees who investigated an imaging tool for use in patients with a rare uterine cancer.
Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.
Pictured: Daniel Thorek & Jan Grimm
In the Lab
Faster than the Speed of Light: New Imaging Approach Could Measure Tumor Activity

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
A cartoon depicting a cleaning crew
In the Lab
Cellular “Garbage Collectors” Are Key to Cancer’s Growth

A new study suggests a way to target cancer by interfering with its system of waste removal.
A person's hand holds a syringe, with its needle inserted into a vial of clear liquid
Reality Check: What You Should Know About Peptides and Cancer

Peptides have become popular with many health and fitness influencers, but experts from MSK say they have concerns about cancer patients using these products because they have not been tested in clinical trials.
a doctor and patient review a scan
Insights About Cachexia, One of Cancer’s Most Common Complications, Hiding in Routine Patient Data

Wasting — called cachexia — affects about half of all cancer patients. An MSK analysis of clinical data from more than 60,000 cancer patients is shedding new light on the condition.
SKI scientists David Scheinberg and Derek Tan
Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs

These souped-up versions may help overcome some limitations of existing CAR T cells.